摘要
糖尿病是一种代谢性疾病,在过去的几十年里,它已成为导致青年和中年发病率和死亡率的一个重要原因,它是第四大导致死亡的疾病。1型和2型糖尿病严重的发病机制会引起微血管并发症如肾病、视网膜病变和神经病变和大血管并发症:心血管疾病,心脏病发作和中风。高血糖状态下,不同信号转导机制的激活、多元醇通路的增加、晚期糖基化终产物的形成、蛋白激酶C和己糖胺通路的激活导致活性氧的过度表达,并导致糖尿病并发症的发病机制。了解糖尿病并发症中这些途径对身体第二系统所造成的损害十分重要。在过去的十年中,对这些生化变化的理解有了很大的进展,许多分子已被利用作为糖尿病并发症的治疗靶点。本文简要介绍了糖尿病和慢性并发症,并对细胞/分子机制和新治疗方法的靶向治疗的最新研究进展进行了讨论
关键词: 糖尿病,并发症,信号传导机制,抗糖尿病药物,靶向治疗。
图形摘要
Current Drug Targets
Title:Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Volume: 17 Issue: 11
Author(s): Krishna A. Adeshara, Arundhati G. Diwan, Rashmi S. Tupe
Affiliation:
关键词: 糖尿病,并发症,信号传导机制,抗糖尿病药物,靶向治疗。
摘要: Diabetes is a metabolic disorder and over the past decades, it has become a major cause of morbidity and mortality affecting the youth and middle-aged as it is the fourth leading cause of disease related to death. In both type 1 and type 2 diabetes the severe pathogenesis cause micro vascular complications: nephropathy, retinopathy, neuropathy and macro vascular complications: cardiovascular disease, heart attacks and stroke. Under hyperglycemia, activation of different signaling mechanisms such as an increased polyol pathway, advanced-glycation end product formation, activation of Protein Kinase C and hexosamine pathway leads to the over expression of reactive oxygen species and causes pathogenesis of diabetic complications. It is necessary to understand these pathways in diabetic complications causing damage to the secondary system of the body. In the past decade the understanding of these biochemical changes has increased tremendously and various molecules have been exploited as therapeutic targets for diabetic complications as better therapeutic approach. In this review, a brief overview about diabetes mellitus and chronic complications with their current understandings of cellular/molecular mechanisms and targeted therapies along with novel therapeutic strategies is discussed.
Export Options
About this article
Cite this article as:
Krishna A. Adeshara, Arundhati G. Diwan, Rashmi S. Tupe , Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies, Current Drug Targets 2016; 17 (11) . https://dx.doi.org/10.2174/1389450117666151209124007
DOI https://dx.doi.org/10.2174/1389450117666151209124007 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenetics Strategies: From Candidate Genes to Whole-Genome Association Analysis. Exploratory or Confirmatory Studies?
Current Pharmacogenomics and Personalized Medicine Natural Antidiabetic Agents: Molecular Docking Study using the Extra Precision Method
Letters in Drug Design & Discovery Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
Current Drug Targets The Central Nervous System as a Promising Target to Treat Diabetes Mellitus
Current Topics in Medicinal Chemistry Exploring the Protective Effect of ShenQi Compound on Skeletal Muscle in Diabetic Macrovasculopathy Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Current Pharmaceutical Design Chymase Inhibitors
Current Pharmaceutical Design New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation
Current Vascular Pharmacology Modulation of Proinflammatory Bacteria- and Lipid-Coupled Intracellular Signaling Pathways in a Transwell Triple Co-Culture Model by Commensal Bifidobacterium Animalis R101-8
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cardiovascular Complications of Obesity
Current Respiratory Medicine Reviews Coronary Calcium Risk Score and Cardiovascular Risk
Current Vascular Pharmacology Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Cardiovascular & Hematological Disorders-Drug Targets Genome-Wide Association Studies of Family Data in Pharmacogenetics: A Case Study
Current Pharmaceutical Design Highly Effective Synthesis of 1-thioamidoalkyl-2-naphthols and Tetrahydropyridines Using a Nanostructured Silica-based Catalyst Under Mild Conditions
Combinatorial Chemistry & High Throughput Screening Recent Advances in Synthetic Chemistry of Diabetic Research
Mini-Reviews in Medicinal Chemistry A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy
Current Diabetes Reviews Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Concepts in Diabetes: Mitochondrial Dynamics and Glucose Homeostasis
Current Diabetes Reviews